22nd Century Group, Inc. (Nasdaq: XXII) is a next-generation plant biotechnology company, focused on improving human health through plant science. Using our breakthrough, patent-protected IP to control nicotine biosynthesis in the tobacco plant, we have developed the first market-ready, reduced nicotine content (RNC) tobacco plants and cigarettes containing 95% less nicotine. We received the first and only FDA MRTP authorization for a combustible cigarette in Dec 2021. The sole function of our cigarettes is to make it easier to reduce the number of cigarettes smoked. xxiicentury.comand 3 more links